The device is worn by patients at risk of ventricular tachycardia or ventricular fibrillation during their hospital stays to monitor for irregular heart rhythms.
When the Hospital Wearable Defibrillator detects a life-threatening heart rhythm, it alerts the patient prior to administering a treatment shock. The device is programmed to deliver fibrillation within 60 seconds of the detected irregularity, according to a company news release.
More articles on supply chain:
Viewpoint: Trump is ‘crying wolf’ on drug price measures
6 must-reads for supply chain leaders this week
Trump nominates Dr. Scott Gottlieb for FDA commissioner: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
